194 related articles for article (PubMed ID: 21220770)
1. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection.
Kouyos RD; von Wyl V; Yerly S; Böni J; Rieder P; Joos B; Taffé P; Shah C; Bürgisser P; Klimkait T; Weber R; Hirschel B; Cavassini M; Rauch A; Battegay M; Vernazza PL; Bernasconi E; Ledergerber B; Bonhoeffer S; Günthard HF;
Clin Infect Dis; 2011 Feb; 52(4):532-9. PubMed ID: 21220770
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of HIV-1 ambiguous nucleotide frequency during antiretroviral treatment interruption.
Li JZ; Christensen JA; Wang H; Spritzler J; Kuritzkes DR;
J Acquir Immune Defic Syndr; 2012 Sep; 61(1):19-22. PubMed ID: 22732468
[TBL] [Abstract][Full Text] [Related]
3. Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies.
Meixenberger K; Hauser A; Jansen K; Yousef KP; Fiedler S; von Kleist M; Norley S; Somogyi S; Hamouda O; Bannert N; Bartmeyer B; Kücherer C
J Clin Microbiol; 2014 Aug; 52(8):2977-83. PubMed ID: 24920768
[TBL] [Abstract][Full Text] [Related]
4. Incident and long-term HIV-1 infection among pregnant women in Brazil: Transmitted drug resistance and mother-to-child transmission.
Lima YA; Cardoso LP; Reis MN; Stefani MM
J Med Virol; 2016 Nov; 88(11):1936-43. PubMed ID: 27037910
[TBL] [Abstract][Full Text] [Related]
5. Sequence ambiguity determined from routine pol sequencing is a reliable tool for real-time surveillance of HIV incidence trends.
Lunar MM; Židovec Lepej S; Poljak M
Infect Genet Evol; 2019 Apr; 69():146-152. PubMed ID: 30682549
[TBL] [Abstract][Full Text] [Related]
6. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
[TBL] [Abstract][Full Text] [Related]
7. Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study.
Papathanasopoulos MA; Vardas E; Wallis C; Glashoff R; Buttó S; Poli G; Malnati M; Clerici M; Ensoli B
AIDS Res Hum Retroviruses; 2010 Jun; 26(6):705-9. PubMed ID: 20509797
[TBL] [Abstract][Full Text] [Related]
8. Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naïve Cameroonian subjects with advanced disease.
Soares EA; Makamche MF; Siqueira JD; Lumngwena E; Mbuagbaw J; Kaptue L; Asonganyi T; Seuánez HN; Soares MA; Alemnji G
J Clin Virol; 2010 Jul; 48(3):173-9. PubMed ID: 20483657
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
[TBL] [Abstract][Full Text] [Related]
10. Genotypic resistance profiles in antiretroviral-naive HIV-1 infections before and after initiation of first-line HAART: impact of polymorphism on resistance to therapy.
Sukasem C; Churdboonchart V; Sukeepaisarncharoen W; Piroj W; Inwisai T; Tiensuwan M; Chantratita W
Int J Antimicrob Agents; 2008 Mar; 31(3):277-81. PubMed ID: 18182278
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 drug resistance transmission networks in southwest Switzerland.
Castro E; Khonkarly M; Ciuffreda D; Bürgisser P; Cavassini M; Yerly S; Pantaleo G; Bart PA
AIDS Res Hum Retroviruses; 2010 Nov; 26(11):1233-8. PubMed ID: 20860534
[TBL] [Abstract][Full Text] [Related]
12. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
[TBL] [Abstract][Full Text] [Related]
14. Short communication: antiretroviral therapy resistance mutations present in the HIV type 1 subtype C pol and env regions from therapy-naive patients in Zambia.
Gonzalez S; Gondwe C; Tully DC; Minhas V; Shea D; Kankasa C; M'soka T; Wood C
AIDS Res Hum Retroviruses; 2010 Jul; 26(7):795-803. PubMed ID: 20623996
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B.
Ndembi N; Abraha A; Pilch H; Ichimura H; Mbanya D; Kaptue L; Salata R; Arts EJ
J Clin Microbiol; 2008 Jan; 46(1):177-84. PubMed ID: 17855574
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
Tebit DM; Sangaré L; Tiba F; Saydou Y; Makamtse A; Somlare H; Bado G; Kouldiaty BG; Zabsonre I; Yameogo SL; Sathiandee K; Drabo JY; Kräusslich HG
J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
[TBL] [Abstract][Full Text] [Related]
17. Genetic relatedness of human immunodeficiency virus-1 (HIV-1) strains in a 12-year-old daughter and her father in a household setting.
Shao J; Wang J; Abubakar YF; Zhou D; Chen J; Shen Y; Wang Z; Lu H
Arch Virol; 2014 Jun; 159(6):1385-91. PubMed ID: 24385159
[TBL] [Abstract][Full Text] [Related]
18. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
[TBL] [Abstract][Full Text] [Related]
19. Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infections.
Ambrosioni J; Junier T; Delhumeau C; Calmy A; Hirschel B; Zdobnov E; Kaiser L; Yerly S;
AIDS; 2012 Oct; 26(16):2079-86. PubMed ID: 23052354
[TBL] [Abstract][Full Text] [Related]
20. Targeting HIV Prevention Based on Molecular Epidemiology Among Deeply Sampled Subnetworks of Men Who Have Sex With Men.
Wang X; Wu Y; Mao L; Xia W; Zhang W; Dai L; Mehta SR; Wertheim JO; Dong X; Zhang T; Wu H; Smith DM
Clin Infect Dis; 2015 Nov; 61(9):1462-8. PubMed ID: 26129754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
